XML 22 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenues $ 54,010 $ 69,202
Cost of revenues 31,423 45,889
Gross profit 22,587 23,313
Operating expenses:    
General and administrative 27,343 41,547
Sales and marketing 13,527 38,489
Research and development 10,349 27,896
Total operating expenses 51,219 107,932
Operating loss (28,632) (84,619)
Other income (expense):    
Interest expense, net (3,191) (1,104)
Common stock warrant liability adjustment (924) 6,337
Other income (expense), net (144) 79
Total other income (expense), net (4,259) 5,312
Loss before income tax provision (32,891) (79,307)
Income tax provision (10) (29)
Net loss and comprehensive loss (32,901) (79,336)
Accretion on Series A convertible preferred stock (4,591) 0
Net loss attributable to common stockholders, basic (37,492) (79,336)
Net loss attributable to common stockholders, diluted $ (37,492) $ (79,336)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (4.53) $ (9.98)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (4.53) $ (9.98)
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares) 8,276,481 7,950,757
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares) 8,276,481 7,950,757